Products for Research Use Only
RegisterLogin

Recaticimab

CAT: 0931-T77144-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T77144-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
2361290-85-7
Target
LDLR, Others
Related Pathways
Metabolism, Others
Purity
0.997
Bioactivity
Recaticimab (SHR-1209) is a humanized monoclonal antibody targeting PCSK9. By binding to PCSK9, Recaticimab promotes LDL receptor stabilization and surface expression on hepatocytes, leading to reduced plasma LDL cholesterol levels. Recaticimab is under study as a therapeutic candidate for hypercholesterolemia and related cardiovascular disorders.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Alternative Products

CatalogName
MBS1563149-01Recaticimab
GTR18337615-01Recaticimab Antibody
C00749-1mg*25Recaticimab (Anti-PCSK9)
047923PCSK9 (recaticimab) discontinued
E55B0790Recaticimab (Reference antibody)
DHJ24010Research Grade Recaticimab
F1458-1Anti-PCSK9 Antibody (Recaticimab)
GTR18315628PCSK9 Reference Antibody (recaticimab)
ICH5808-1mgRecaticimab Biosimilar - Research Grade
21-957Recaticimab - Research Grade Biosimilar

Popular Products